Reversible cerebral hypoperfusion in Lyme encephalopathy

Neurology

Volumn 49, Issue 6, 1997, Pages 1661-1670

  Logigian, E L ^a   Johnson, Keith A ^a,e   Kijewski, M F ^a   Kaplan, R F ^b   Becker, J A ^a,c   Jones, K J ^d   Garada, B M ^a   Holman, B L ^a   Steere, A C ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d BRANDEIS UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE;

ADULT; AGED; ARTICLE; BORRELIA BURGDORFERI; BRAIN DISEASE; BRAIN PERFUSION; BRAIN REGION; CLINICAL ARTICLE; FEMALE; HUMAN; LYME DISEASE; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031470270     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.6.1661     Document Type: Article

References (51)

1. Halperin JJ, Pass HL, Anand AK, Luft BJ, Volkman DJ, Dattwyler RJ. Nervous system abnormalities in Lyme disease. Ann NY Acad Sci 1988;539:24-34.
2. Halperin JJ, Krupp LB, Golightly MG, Volkman DJ. Lyme borreliosis-associated encephalopathy. Neurology 1990;40: 1340-1343.
3. Halperin JJ, Luft BJ, Anand AK, et al. Lyme neuroborreliosis: central nervous system manifestations. Neurology 1989;39: 753-759.
4. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease: encephalopathy, polyneuropathy and leukoencephalitis. N Engl J Med 1990;323:1438-1444.
5. Krupp LB, Masur D, Schwartz J, et al. Cognitive functioning in late Lyme neuroborreliosis. Arch Neurol 1991;48:1125-1129.
6. Kaplan RA, Meadows M, Vincent LC, Logigian EL, Steere AC. Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and nonpsychotically depressed patients. Neurology 1992;42:1263-1267.
7. Steere AC, Berardi VP, Weeks KE, Logigian EL, Ackermann R. Evaluation of the intrathecal antibody response to Borrelia burgdorferi. J Infect Dis 1990;161:1203-1209.
8. Fernandez RE, Rothberg M, Ferencz G, Wujack D. Lyme disease of the CNS: MR imaging findings in 14 cases. Am J Neuroradiol 1990;11:479-481.
9. Belman AL, Coyle PK, Roque C, Cantos E. MRI findings in children infected by Borrelia burgdorferi. Pediatr Neurol 1992;8:428-431.
10. Cutler NR, Haxby JV, Duara R, et al. Clinical history, metabolism, and neuropsychological function in Alzheimer's disease. Ann Neurol 1985;18:298-309.
11. Foster NL, Chase TN, Dedio P, Patronas NJ, Brooks RA, DiChiro G. Alzheimer's disease: focal changes shown by positron emission tomography. Neurology 1983;33:961-965.
12. Neary D, Snowden JS, Shields RA, et al. Single photon emission tomography using Tc-99m HMPAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987;50:1101-1109.
13. Johnson KA, Mueller ST, Walshe TM, English RJ, Holman BL. Cerebral perfusion imaging in Alzheimer's disease: use of single photo emission computed tomography and iofetamine hydrochloride I-123. Arch Neurol 1987;44:165-168.
14. 2. J Nucl Med 1990;31:1595-1600.
15. Johnson KA, Holman BL, Mueller SP, et al. Single photon emission computed tomography in Alzheimer's disease: abnormal iofetamine I-123 uptake reflects dementia severity. Arch Neurol 1988;45:392-396.
16. Johnson KA, Holman BL, Rosen TJ, Nagel JS, English RJ, Growdon JH, Iofetamine I-123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease. Arch Intern Med 1990;150:752-756.
17. Hellman RS, Tikofsky RS, Collier BD, et al. Alzheimer's disease: quantitative analysis of I-123 iodoamphetamine SPECT brain imaging. Radiology 1989;172:183-188.
18. DeKosky ST, Shih WJ, Schmitt FA, et al. Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer's disease: correlation with cognitive severity. Alzheimer Dis Assoc Disord 1990;4:14-23.
19. Jagust WJ, Budinger TF, Reed BR. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol 1987;44:258-262.
20. Reed PR, Jagust WJ, Seab JP, et al. Memory and regional cerebral blood flow in mildly symptomatic Alzheimer's disease. Neurology 1989;39:1537-1539.
21. Burns A, Philpot M, Costa D, et al. The investigation of Alzheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry 1989;52:248-253.
22. Johnson K, Kijewski MF, Becker JA, Garada B, Satlin A, Holman B. Quantitative brain SPECT in Alzheimer's disease and normal aging. J Nucl Med 1993;34:2044-2048.
23. Johnson K, Sperling R, Holman B, Nagel J, Growdon J. Cerebral perfusion in progressive supranuclear palsy. J Nucl Med 1992;33:704-709.
24. Haxby J, Grady C, Duara R, Schlageter N, Berg G, Rapoport S. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's disease-type dementia. Arch Neurol 1986;43:882-885.
25. Epidemiology Section, State of Connecticut Department of Health Services. Lyme disease in Connecticut. Connecticut Epidemiologist 1990;10:9-12.
26. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993;167:392-400.
27. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR 1995;44:590.
28. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994;330:229-234.
29. Nocton JJ, Bloom BJ, Rutledge BJ, et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 1996;174:623-626.
30. Holman BL, Carvalho PA, Zimmerman RE, et al. Brain perfusion SPECT using an annular single crystal camera: initial clinical experience. J Nucl Med 1990;31:1456-1461.
31. Genna S, Smith AP. The development of ASPECT, an annular single crystal brain camera for high efficiency SPECT. IEEE Trans Nucl Sci 1988;NS-35:654-658.
32. Chang L-T. A method for attenuation correlation in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;NS-25:638-643.
33. Becker JA Johnson KA, et al. A unified processing environment for image fusion. J Nucl Med 1993;34:179.
34. Kleinbaum DG, Kupper LL. Applied regression analysis and other multivariable methods. North Scituate, MA: Duxbury Press, 1978.
35. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS. The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab 1990;10: 458-466.
36. Winer BJ. Statistical principles in experimental design. 2nd ed. New York: McGraw Hill, 1971.
37. Rahn DW, Malawista SE. Lyme disease: recommendations for diagnosis and treatment. Ann Intern Med 1991;114:472-401.
38. Holman BL, Garada B, Johnson KA, et al. A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. J Nucl Med 1992;33:1312-1315.
39. Schwartz RB, Komaroff AL, Garada BM, et al. SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex and major unipolar depression. AJR Am J Roentgenol 1994;162:943-951.
40. Mayberg HS, Lewis PJ, Regenold W, Wagner HN. Paralimbic hypoperfusion in unipolar depression. J Nucl Med 1994;35: 929-934.
41. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA 1993;269:1812-1816.
42. Halperin JJ, Heyes MP. Neuroactive kynurenines in Lyme borreliosis. Neurology 1992;42:43-50.
43. Power C, Kong P-A, Crawford TO, et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 1993; 34:339-350.
44. Mesulam M-M. Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 1990;28:597-613.
45. Rosci MA, Pigorini F, Bernabei A, Pau FM, Merigliano DE, Meligrana MF. Neuropsychological and neurodiagnostic imaging (MR-SPECT) early signs of AIDS dementia complex (ADC) in asymptomatic, HIV-1 infected subjects [abstract PoB 3784]. Int Conf AIDS 1992;8:B221.
46. Ackermann R, Rhese-Kupper B, Gollmer E. Progressive Borrelien-enzephalomyelitis. Dtsch Med Wochenschr 1985; 110:1039-1042.
47. Ackermann R, Rhese-Kupper B, Gollmer E. Progressive borrelia encephalomyelitis. Zbl Bakt Hyg A 1986;263:297-300.
48. Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 1991;41: 1571-1582.
49. Reik L, Smith L, Khan A, Nelson W. Demyelinating encephalopathy in Lyme disease. Neurology 1985;35:267-269.
50. Garcia-Monco JC, Fernandez-Villar B, Benach JL. Adherence of the Lyme disease spirochete to glial cells and cells of glial origin. J Infect Dis 1989;160:497-506.
51. Garcia-Monco JC, Fernandez-Villar B, Szczepanski A, Benach JL. Cytoxicity of Borrelia burgdorferi for cultured rat glial cells. J Infect Dis 1991;163:1362-1366.